Market Overview

UPDATE: Wedbush Securities Reiterates Neutral Rating, Raises PT on CIGNA Corporation

Share:
Related CI
Aetna Still Undecided On Coverage For Sarepta's Highly Debated Muscular Dystrophy Treatment
A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Economic Data
UnitedHealth, The Amazon Of Health Care, Isn't Sweating Trump (Investor's Business Daily)

In a report published Friday, Wedbush Securities reiterated its Neutral rating on CIGNA Corporation (NYSE: CI), and raised its price target from $53.00 to $57.00.

Wedbush noted, “Three of the 4 largest health plans now looking for commercial enrollment pressures in 2013, anticipate similar comments from WLP next week. United and Aetna both indicated there could be commercial enrollment losses, CIGNA is expecting around 2% declines in the national account segment (employers >5K and multi-state). All three companies are pointing towards a shrinking market driven by continued high unemployment, Aetna and United pointed to continued competitiveness in the market. CIGNA could see some benefit over peers driven by high retention levels.”

CIGNA Corporation closed on Thursday at $53.27.

Latest Ratings for CI

DateFirmActionFromTo
Sep 2016Evercore ISI GroupInitiates Coverage onHold
Aug 2016CitigroupMaintainsBuy
Aug 2016JefferiesMaintainsBuy

View More Analyst Ratings for CI
View the Latest Analyst Ratings

Posted-In: Wedbush SecuritiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (CI)

View Comments and Join the Discussion!